PSYENCE BIOMEDICAL LTD Research and Development Expense
PSYENCE BIOMEDICAL LTD (PBM) reported Research and Development Expense of $357.44 thousand for the 3-month period ending 2025-09-30, per its 6-K filed 2025-11-20.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2025-11-20
- PSYENCE BIOMEDICAL LTD research and development expense for the quarter ending 2025-09-30 was $357.44K, a 34.57% increase year-over-year.
- PSYENCE BIOMEDICAL LTD research and development expense for the quarter ending 2024-09-30 was $265.63K.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|---|
| 2025-09-30 | $357.44K 6-K · filed 2025-11-20 | $672.36K 6-K · filed 2025-11-20 | |
| 2025-03-31 | $342.17K 20-F · filed 2025-06-25 | ||
| 2024-09-30 | $265.63K 6-K · filed 2025-11-20 | $265.63K 6-K · filed 2025-11-20 | |
| 2024-03-31 | $954.59K 20-F · filed 2025-06-25 | ||
| 2023-03-31 | $1.61M 20-F · filed 2025-06-25 |